1. "Biology of Blood and Marrow Transplantation"
  2. "James Young"
Formats
  1. Meeting Abstract (51)
  2. Journal Article (30)
Groups
  1. Bone Marrow Transplant (81)
  2. Center for Hematologic Malignancies (81)
  3. Department of Medicine (81)
  4. Hematologic Malignancies, Division of (81)
  5. Survivorship Research (66)
  6. GSK Faculty (59)

More Groups

People
  1. James Young (81)
  2. Esperanza Papadopoulos (63)
  3. Ann Jakubowski (60)
  4. Miguel-Angel Perales (58)
  5. Sergio Giralt (55)
  6. Hugo Castro-Malaspina (53)

More People

Years
  1. 2020 (8)
  2. 2019 (5)
  3. 2018 (4)
  4. 2017 (6)
  5. 2016 (9)
  6. 2015 (8)

More Years

Publications
  1. Biology of Blood and Marrow Transplantation (81)
Publishers
  1. Elsevier Inc. (81)

Results (81)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Host T-cells contribute to immune reconstitution and improved outcome in recipients of CD34 selected T-cell depleted allografts (TCD HCT) with full hematopoietic cell but persistent mixed T-cell chimerism
    Meeting Abstract

    O'Reilly, R. J.; Koehne, G.; Heller, G.; Boulad, F.; Castro-Malaspina, H.; Giralt, S. A.; Jakubowski, A. A.; Kernan, N. A.; Papadopoulos, E. B.; Perales, M.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • The impact of individual co-morbidities in myeloablative ex vivo CD34+ selected allogeneic hematopoietic cell transplantation
    Meeting Abstract

    Shouval, R.; Fein, J. A.; Devlin, S. M.; Maloy, M. A.; Castillo Flores, N.; Lin, R. J.; Politikos, I.; Sanchez, M.; Scordo, M.; Shah, G. L.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Don't let the HCT-CI fool you: Similar outcomes with myeloablative CD34+ selected allo-HCT compared to unmodified RIC allo-HCT in patients with AML or MDS and high comorbidity scores
    Meeting Abstract

    Pennisi, M.; Cho, C.; Devlin, S. M.; Ruiz, J. D.; Maloy, M. A.; Tomas, A. A.; Castillo, N.; Lin, R. J.; Politikos, I.; Sanchez-Escamilla, M.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Long-term survival in patients with AML or MDS relapsed after allogeneic hematopoietic cell transplantation: Importance of second cell therapy
    Meeting Abstract

    Zuanelli Brambilla, C.; Ruiz, J. D.; Lobaugh, S. M.; Dahi, P. B.; Young, J. W.; Gyurkocza, B.; Shaffer, B. C.; Ponce, D. M.; Tamari, R.; Sanchez Escamilla, M.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Burden and impact of geriatric syndromes in 2-year, progression-free survivors of older allogeneic hematopoietic cell transplant recipients - A landmark analysis
    Meeting Abstract

    Lin, R. J.; Baser, R. E.; Elko, T. A.; Korc-Grodzicki, B.; Shahrokni, A.; Maloy, M. A.; Young, J. W.; Tamari, R.; Shah, G. L.; Shaffer, B. C.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Evaluation of tumor vaccine generation in a phase II multicenter trial of single autologous hematopoietic cell transplant (autoHCT) followed by lenalidomide maintenance for multiple myeloma (MM) with or without vaccination with dendritic cell/myeloma fusions (DC/MM fusion vaccine): Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 1401
    Meeting Abstract

    Avigan, D. E.; Shah, N.; Logan, B.; Zhu, J.; Bisharat, L.; Callander, N. S.; Chodon, T.; Dhakal, B.; Efebera, Y. A.; Geller, N.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Outcomes of two chemotherapy-based preparatory regimens compared to tbi-based conditioning when used with CD34(+) selected T-cell depleted alloHCT for high risk hematologic malignancies: Prospective clinical trial NCT 01119066
    Meeting Abstract

    O'Reilly, R. J.; Koehne, G.; Boulad, F.; Heller, G.; Klein, E.; Barker, J. N.; Castro-Malaspina, H.; Curran, K. J.; Hsu, K. C.; Jakubowski, A. A.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Ex vivo T cell-depleted hematopoietic stem cell transplantation for adult patients with acute myelogenous leukemia in first and second remission: Long-term disease-free survival with a significantly reduced risk of graft-versus-host disease
    Journal Article

    Montoro, J.; Ceberio, I.; Hilden, P.; Maloy, M. A.; Barker, J.; Castro-Malaspina, H.; Dahi, P.; Koehne, G.; Perales, M. A.; Ponce, D.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Efficacy of donor and 'third party' (Tabelecleucel) EBV-specific T cells for treatment of central nervous system (CNS) EBV-PTLD
    Meeting Abstract

    Prockop, S. E.; Suser, S.; Doubrovina, E. S.; Castro-Malaspina, H.; Papadopoulos, E. B.; Sauter, C. S.; Young, J. W.; Szenes, V.; Slocum, A.; Baroudy, K.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Comparison of double unit cord blood transplants (dCBT) with 8/8 HLA-allele matched related (MRD) or unrelated donor (MUD) T-cell depleted (TCD) transplants in adults with myeloid malignancies: Comparable progression-free survival (PFS)
    Meeting Abstract

    Politikos, I.; Cho, C.; Devlin, S. M.; Maloy, M. A.; Naputo, K.; O'Reilly, R. J.; Scaradavou, A.; Castro-Malaspina, H.; Dahi, P. B.; Gyurkocza, B.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save